Health Catalyst (HCAT) Shares Outstanding (2018 - 2026)

Health Catalyst (HCAT) has 9 years of Shares Outstanding data on file, last reported at $73.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 6.14% year-over-year to $73.7 million; the trailing twelve-month figure through Mar 2026 stood at $73.7 million (up 6.14% YoY), and the FY2025 full-year result was $72.1 million, up 12.63% from the prior year.
• Shares Outstanding for Q1 2026 stood at $73.7 million, up from $72.1 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $73.9 million in Q1 2026 and bottomed at $53.5 million in Q1 2022.
• The 5-year median for Shares Outstanding is $59.0 million (2024), against an average of $61.5 million.
• The widest annual swing landed in 2022, when Shares Outstanding advanced 20.64%; it then advanced 4.39% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $55.3 million in 2022, then increased by 5.49% to $58.3 million in 2023, then increased by 9.86% to $64.0 million in 2024, then climbed by 12.63% to $72.1 million in 2025, then rose by 2.24% to $73.7 million in 2026.
• The last three Shares Outstanding figures came in at $73.7 million (Q1 2026), $72.1 million (Q4 2025), and $70.7 million (Q3 2025), per Business Quant data.

Peer Comparison